Back to Directory
Last Updated: 04/06/2026

Optibrium

Cambridge
Founded 2009
In silico software and AI for small molecule drug discovery

Optibrium is a software company providing integrated computational platforms for small molecule design, optimisation and data analysis across preclinical drug discovery.

Its tools support compound property prediction, multi-parameter optimisation, AI-driven data analysis, de novo design, and structure-based modelling, enabling discovery teams to make more informed decisions at the hit-to-lead and lead optimisation stages.

The company serves pharmaceutical, biotechnology and agrochemical organisations globally.